One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Same-Day Discharge After Elective Percutaneous Transcatheter Cardiovascular Interventions
Amar Krishnaswamy, MD,a, * Toshiaki Isogai, MD, MPH,a, * Emmanouil S. Brilakis, MD, PHD, b Aravinda Nanjundappa, MBBS, a Khaled M. Ziada, MD,a Sahil A. Parikh, MD,c Josep Rodés-Cabau, MD, P HD, d Stephan Windecker, MD, e Samir R. Kapadia, MD
doi : 10.1016/j.jcin.2023.05.015
Volume 16, Issue 13, 10 July 2023, Pages 1561-1578
Percutaneous transcatheter interventions have evolved as standard therapies for a variety of cardiovascular diseases, from revascularization for atherosclerotic vascular lesions to the treatment of structural cardiac diseases. Concomitant technological innovations, procedural advancements, and operator experience have contributed to effective therapies with low complication rates, making early hospital discharge safe and common.
Characterization of Screen Failures Among Patients Evaluated for Transcatheter Tricuspid Valve Repair (TriSelect-Study)
Muhammed Gerçek, MD, a,b Arseniy Goncharov, MD, a Akhil Narang, MD,b Maria l. K?rber, MD,c Kai P. Friedrichs, MD,a Abigail S. Baldridge, MS, b Zhiying Meng, MS, b Jyothy J. Puthumana, MD, b Laura J. Davidson, MD, b S. Christopher Malaisrie, MD,b James D. Thomas, MD,b Tanja K. Rudolph, MD, a Roman Pfister, MD, c Volker Rudolph, MD, a Charles J. Davidson, MD
doi : 10.1016/j.jcin.2023.03.036
Volume 16, Issue 13, 10 July 2023, Pages 1579-1589
Screen Failures for Transcatheter Tricuspid Valve Repair: Implications for Patient Management and Future Innovation∗
Azeem Latib, MD, Andrea Scotti, MD
doi : 10.1016/j.jcin.2023.05.023
Volume 16, Issue 13, 10 July 2023, Pages 1590-1593
Bioprosthetic Valve Remodeling in Nonfracturable Surgical Valves: Impact on THV Expansion and Hydrodynamic Performance
David Meier, MD, a,b,c Thomas Puehler, MD,d,e Georg Lutter, MD, d,e Carol Shen, b Althea Lai, BSC ,b Hacina Gill, BS C,b Mariama Akodad, MD, P HD, a,b,c,f Georgios Tzimas, MD, c Adnan Chhatriwalla, MD, g Keith B. Allen, MD, g Philipp Blanke, MD,c Geoffrey W. Payne, MS C, P HD, h David A. Wood, MD,a,c Jonathon A. Leipsic, MD, c John G. Webb, MD, a,c Stephanie L. Sellers, MS C, PHD, a,b,c, * Janarthanan Sathananthan, MBC HB, MPH
doi : 10.1016/j.jcin.2023.03.035
Volume 16, Issue 13, 10 July 2023, Pages 1594-1608
Bioprosthetic Valve Remodeling in Transcatheter Aortic Valve-in-Valve Replacement: From Bench Testing to Clinical Implications∗
Firas Zahr, MD, Harsh Golwala, MD
doi : 10.1016/j.jcin.2023.04.024
Volume 16, Issue 13, 10 July 2023, Pages 1609-1611
Evolution and Prognostic Impact of Right Ventricular–Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement
Maria Chiara Meucci, MD, a,b Silvia Malara, MD, c Steele C. Butcher, MD, MP HIL, b,d Kensuke Hirasawa, MD, P HD, b,e Frank van der Kley, MD, PHD, b Antonella Lombardo, MD, a,c Cristina Aurigemma, MD, P HD, a Enrico Romagnoli, MD, PH D, a Carlo Trani, MD, a,c Massimo Massetti, MD,a,c Francesco Burzotta, MD, PHD, a,c Jeroen J. Bax, MD, PH D, b,f Filippo Crea, MD, P HD, a,c Nina Ajmone Marsan, MD, PHD, b, * Francesca Graziani, MD, PH D
doi : 10.1016/j.jcin.2023.05.003
Volume 16, Issue 13, 10 July 2023, Pages 1612-1621
There is limited evidence regarding the association between right ventricular-to-pulmonary artery (RV-PA) coupling and outcomes after transcatheter aortic valve replacement (TAVR).
Right Ventricular–Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement: Closer to Optimal Prognosis Assessment?∗
Vincent Auffret, MD, P HD, Guillaume Leurent, MD
doi : 10.1016/j.jcin.2023.05.049
Volume 16, Issue 13, 10 July 2023, Pages 1622-1625
First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
Syed Zaid, MD, a Guilherme F. Attizzani, MD,b Parasuram Krishnamoorthy, MD, c Sung-Han Yoon, MD, b Luis A. Palma Dallan, MD, b Stanley Chetcuti, MD,d Shinichi Fukuhara, MD, d P. Michael Grossman, MD, d Sachin S. Goel, MD,a Marvin D. Atkins, MD,a Neal S. Kleiman, MD, a Rishi Puri, MD, PH D, e Beka Bakhtadze, MD,e Timothy Byrne, DO, f Akram W. Ibrahim, MD,f Kendra J. Grubb, MD,g Andy Tully, MD,g Howard C. Herrmann, MD,h Michela Faggioni, MD, h Basel Ramlawi, MD, i Sahil Khera, MD, MPH, c Stamatios Lerakis, MD, P HD, c George D. Dangas, MD, P HD, c Annapoorna S. Kini, MD, c Samin K. Sharma, MD, c Michael J. Reardon, MD,a Gilbert H.L. Tang, MD, MS C, MBA c
doi : 10.1016/j.jcin.2023.05.004
Volume 16, Issue 13, 10 July 2023, Pages 1626-1635
The latest-generation Evolut FX TAVR system (Medtronic) offers several potential design improvements over its predecessors, but early reported experience has been limited.
The Perfect Valve∗
John G. Webb, MD, Janar Sathananthan, MD, David A. Wood, MD
doi : 10.1016/j.jcin.2023.05.037
Volume 16, Issue 13, 10 July 2023, Pages 1636-1639
Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry
Seung-Jun Lee, MD,a, * Hyeok-Hee Lee, MD,a,b, * Young-Guk Ko, MD,a Chul-Min Ahn, MD,a Yong-Joon Lee, MD,a Jung-Sun Kim, MD,a Byeong-Keuk Kim, MD,a Myeong-Ki Hong, MD, a Hyeon Chang Kim, MD, b Cheol Woong Yu, MD,c Jae-Hwan Lee, MD, d Seung-Whan Lee, MD,e Young Jin Youn, MD, f Jong Kwan Park, MD,g Chang-Hwan Yoon, MD, h,i Seung Woon Rha, MD,j Pil-Ki Min, MD, k Seung-Hyuk Choi, MD, l In-Ho Chae, MD, h,i Donghoon Choi, MD, a on behalf of the K-VIS Investigators
doi : 10.1016/j.jcin.2023.05.002
Volume 16, Issue 13, 10 July 2023, Pages 1640-1650
Is Drug-Coated Balloon the Real Winner for Femoropopliteal Artery Intervention?∗
Francesco Liistro, MD
doi : 10.1016/j.jcin.2023.05.048
Volume 16, Issue 13, 10 July 2023, Pages 1651-1653
Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent Implantation: Risk Factors and Clinical Outcomes
Andrew Holden, MBC HB,a Yann Gouëffic, MD, PH D, b William A. Gray, MD,c Elizabeth J. Davis, PH D, d Ido Weinberg, MD,e Michael R. Jaff, DO d
doi : 10.1016/j.jcin.2023.04.037
Volume 16, Issue 13, 10 July 2023, Pages 1654-1664
Hypoechoic peri-stent areas in duplex ultrasonography (DUS) (ie, “halo�) have been noted following femoropopliteal artery stenting.
Hypoechoic Halos After Femoropopliteal Stenting: Looking Beyond the Borders∗
Salvatore Cassese, MD, PHD, Felix Voll, MD
doi : 10.1016/j.jcin.2023.05.039
Volume 16, Issue 13, 10 July 2023, Pages 1665-1667
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
S. Elissa Altin, MD,a,b Helen Parise, SCD, a Connie N. Hess, MD, MHS, c,d Ning A. Rosenthal, MD, MPH, PH D, e Mark A. Creager, MD,f Herbert D. Aronow, MD,g Jeptha P. Curtis, Mda
doi : 10.1016/j.jcin.2023.05.001
Volume 16, Issue 13, 10 July 2023, Pages 1668-1678
In patients with intermittent claudication (IC), short-term amputation rates from clinical trial data following lower extremity femoropopliteal (FP) peripheral vascular intervention (PVI) are <1% with unknown longer-term rates.
Optimal Management of Femoropopliteal Arterial Disease in Patients With Intermittent Claudication∗
Debabrata Mukherjee, MD, MS
doi : 10.1016/j.jcin.2023.05.040
Volume 16, Issue 13, 10 July 2023, Pages 1679-1681
TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design
Philippe Nuyens, MD,a Ole De Backer, MD, P HD, a Janarthanan Sathananthan, MBC HB, MPH,b,c Troels H?jsgaard J?rgensen, MD, PHD, a Hendrik Treede, MD, PH D, d Jonathon A. Leipsic, MD, P HD, b Jeroen J. Bax, MD, PH D, e John G. Webb, MD, b,c Roxana Mehran, MD,f Mao Chen, MD, P HD, g Michael Reardon, MD,h Martin B. Leon, MD, i,j Lars S?ndergaard, MD, DMS C a
doi : 10.1016/j.jcin.2023.04.003
Volume 16, Issue 13, 10 July 2023, Pages 1682-1687
A Case of Obstructive Shock in Bioprosthetic Pulmonic Valve Endocarditis
Ahmad A. Al Turk, MD, Jake Martinez, MD, I-Hui Chiang, MD, Philip A. Gideon, MD, Marvin H. Eng, MD
doi : 10.1016/j.jcin.2023.02.013
Volume 16, Issue 13, 10 July 2023, Pages 1688-1689
Double Device Approach for Percutaneous Closure of Postmyocardial Infarction Ventricular Septal Defect
Elena de Oliveira-Ca?edo, MD, a, * Joan F. Andrés-Cordon, MD, a,b, * Gerard Mart?-Aguasca, MD,c Victoria Vilalta, MD, a Eduard Fern?ndez-Nofrer?as, MD
doi : 10.1016/j.jcin.2023.03.026
Volume 16, Issue 13, 10 July 2023, Pages 1690-1691
Phrenic Nerve Injury Following Bicaval Valve Implantation for Treating Severe Tricuspid Regurgitation
Omar Abdul-Jawad Altisent, MD, a Rishi Puri, MBBS, PH D, b Ander Regueiro, MD, P HD, a Laura Sanchis, MD, PH D, a Marta Sitges, MD, PHD, a Salvatore Brugaleta, MD, P HD, a Manel Sabaté, MD, P HD, a Josep Rodés-Cabau, MD, P HD, a,c Xavi Freixa, MD, P HD
doi : 10.1016/j.jcin.2023.03.048
Volume 16, Issue 13, 10 July 2023, Pages 1692-1693
Distinctive Paravalvular Jets of a Novel Self-Expanding Transcatheter Aortic Valve With a Unique Skirt Design
Elena Romero Dorta, MD,a,b Isabel Mattig, MD, a,b,c,d Lorenz K?sters, a,b Simon H. Sündermann, MD,b,c,e Sebastian Spethmann, MD, a,b,c Karl Stangl, MD, a,b,c Henryk Dreger, MD
doi : 10.1016/j.jcin.2023.05.006
Volume 16, Issue 13, 10 July 2023, Pages 1694-1695
Dual Retrograde Tibial Access Thrombectomy for Acute Limb Ischemia
Kei Ichihashi, MD, Kazuhiro Dan, MD, PHD
doi : 10.1016/j.jcin.2023.04.039
Volume 16, Issue 13, 10 July 2023, Pages 1696-1697
Association of TRI-SCORE With Clinical Outcomes After Transcatheter Tricuspid Valve Repair
Johanna Vogelhuber, MDy *Tetsu Tanaka, MDy Atsushi Sugiura, MD, PhD Natalia Galka, MS Hannah Emmi Hupp-Herschel, MS Marc Ulrich Becher, MD Sebastian Zimmer, MD Georg Nickenig, MD Refik Kavsur, MDz Marcel Weber, MD
doi : 10.1016/j.jcin.2023.04.005
Volume 16, Issue 13, 10 July 2023, Pages 1698-1700
Basal Septal Bulge as Risk Factor for New Conduction Disorders After Transcatheter Aortic Valve Replacement
Tanja Kochy Stephanie Brunner, MDy Federico Moccetti, MD Mathias Wolfrum, MD *Stefan Toggweiler, MD
doi : 10.1016/j.jcin.2023.04.041
Volume 16, Issue 13, 10 July 2023, Pages 1701-1702
Low-Cardiac Output Syndrome After Tricuspid Valve Repair: Insights From the TriValve Registry
Karl-Philipp Rommel, MD Maurizio Taramasso, MD Sebastian Ludwig, MD Guillaume Bonnet, MD, PhD Holger Thiele, MD Martin B. Leon, MD Francesco Maisano, MD Daniel Burkhoff, MD Rebecca T. Hahn, MD Philipp Lurz, MD, PhD
doi : 10.1016/j.jcin.2023.05.010
Volume 16, Issue 13, 10 July 2023, Pages 1703-1705
Same-Day Discharge After Elective Percutaneous Transcatheter Cardiovascular Interventions
Amar Krishnaswamy, MD,a, * Toshiaki Isogai, MD, MPH,a, * Emmanouil S. Brilakis, MD, PHD, b Aravinda Nanjundappa, MBBS, a Khaled M. Ziada, MD,a Sahil A. Parikh, MD,c Josep Rodés-Cabau, MD, P HD, d Stephan Windecker, MD, e Samir R. Kapadia, MD
doi : 10.1016/j.jcin.2023.05.015
Volume 16, Issue 13, 10 July 2023, Pages 1561-1578
Percutaneous transcatheter interventions have evolved as standard therapies for a variety of cardiovascular diseases, from revascularization for atherosclerotic vascular lesions to the treatment of structural cardiac diseases. Concomitant technological innovations, procedural advancements, and operator experience have contributed to effective therapies with low complication rates, making early hospital discharge safe and common.
Characterization of Screen Failures Among Patients Evaluated for Transcatheter Tricuspid Valve Repair (TriSelect-Study)
Muhammed Gerçek, MD, a,b Arseniy Goncharov, MD, a Akhil Narang, MD,b Maria l. K?rber, MD,c Kai P. Friedrichs, MD,a Abigail S. Baldridge, MS, b Zhiying Meng, MS, b Jyothy J. Puthumana, MD, b Laura J. Davidson, MD, b S. Christopher Malaisrie, MD,b James D. Thomas, MD,b Tanja K. Rudolph, MD, a Roman Pfister, MD, c Volker Rudolph, MD, a Charles J. Davidson, MD
doi : 10.1016/j.jcin.2023.03.036
Volume 16, Issue 13, 10 July 2023, Pages 1579-1589
Screen Failures for Transcatheter Tricuspid Valve Repair: Implications for Patient Management and Future Innovation∗
Azeem Latib, MD, Andrea Scotti, MD
doi : 10.1016/j.jcin.2023.05.023
Volume 16, Issue 13, 10 July 2023, Pages 1590-1593
Bioprosthetic Valve Remodeling in Nonfracturable Surgical Valves: Impact on THV Expansion and Hydrodynamic Performance
David Meier, MD, a,b,c Thomas Puehler, MD,d,e Georg Lutter, MD, d,e Carol Shen, b Althea Lai, BSC ,b Hacina Gill, BS C,b Mariama Akodad, MD, P HD, a,b,c,f Georgios Tzimas, MD, c Adnan Chhatriwalla, MD, g Keith B. Allen, MD, g Philipp Blanke, MD,c Geoffrey W. Payne, MS C, P HD, h David A. Wood, MD,a,c Jonathon A. Leipsic, MD, c John G. Webb, MD, a,c Stephanie L. Sellers, MS C, PHD, a,b,c, * Janarthanan Sathananthan, MBC HB, MPH
doi : 10.1016/j.jcin.2023.03.035
Volume 16, Issue 13, 10 July 2023, Pages 1594-1608
Bioprosthetic Valve Remodeling in Transcatheter Aortic Valve-in-Valve Replacement: From Bench Testing to Clinical Implications∗
Firas Zahr, MD, Harsh Golwala, MD
doi : 10.1016/j.jcin.2023.04.024
Volume 16, Issue 13, 10 July 2023, Pages 1609-1611
Evolution and Prognostic Impact of Right Ventricular–Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement
Maria Chiara Meucci, MD, a,b Silvia Malara, MD, c Steele C. Butcher, MD, MP HIL, b,d Kensuke Hirasawa, MD, P HD, b,e Frank van der Kley, MD, PHD, b Antonella Lombardo, MD, a,c Cristina Aurigemma, MD, P HD, a Enrico Romagnoli, MD, PH D, a Carlo Trani, MD, a,c Massimo Massetti, MD,a,c Francesco Burzotta, MD, PHD, a,c Jeroen J. Bax, MD, PH D, b,f Filippo Crea, MD, P HD, a,c Nina Ajmone Marsan, MD, PHD, b, * Francesca Graziani, MD, PH D
doi : 10.1016/j.jcin.2023.05.003
Volume 16, Issue 13, 10 July 2023, Pages 1612-1621
There is limited evidence regarding the association between right ventricular-to-pulmonary artery (RV-PA) coupling and outcomes after transcatheter aortic valve replacement (TAVR).
Right Ventricular–Pulmonary Artery Coupling After Transcatheter Aortic Valve Replacement: Closer to Optimal Prognosis Assessment?∗
Vincent Auffret, MD, P HD, Guillaume Leurent, MD
doi : 10.1016/j.jcin.2023.05.049
Volume 16, Issue 13, 10 July 2023, Pages 1622-1625
First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
Syed Zaid, MD, a Guilherme F. Attizzani, MD,b Parasuram Krishnamoorthy, MD, c Sung-Han Yoon, MD, b Luis A. Palma Dallan, MD, b Stanley Chetcuti, MD,d Shinichi Fukuhara, MD, d P. Michael Grossman, MD, d Sachin S. Goel, MD,a Marvin D. Atkins, MD,a Neal S. Kleiman, MD, a Rishi Puri, MD, PH D, e Beka Bakhtadze, MD,e Timothy Byrne, DO, f Akram W. Ibrahim, MD,f Kendra J. Grubb, MD,g Andy Tully, MD,g Howard C. Herrmann, MD,h Michela Faggioni, MD, h Basel Ramlawi, MD, i Sahil Khera, MD, MPH, c Stamatios Lerakis, MD, P HD, c George D. Dangas, MD, P HD, c Annapoorna S. Kini, MD, c Samin K. Sharma, MD, c Michael J. Reardon, MD,a Gilbert H.L. Tang, MD, MS C, MBA c
doi : 10.1016/j.jcin.2023.05.004
Volume 16, Issue 13, 10 July 2023, Pages 1626-1635
The latest-generation Evolut FX TAVR system (Medtronic) offers several potential design improvements over its predecessors, but early reported experience has been limited.
The Perfect Valve∗
John G. Webb, MD, Janar Sathananthan, MD, David A. Wood, MD
doi : 10.1016/j.jcin.2023.05.037
Volume 16, Issue 13, 10 July 2023, Pages 1636-1639
Device Effectiveness for Femoropopliteal Artery Disease Treatment: An Analysis of K-VIS ELLA Registry
Seung-Jun Lee, MD,a, * Hyeok-Hee Lee, MD,a,b, * Young-Guk Ko, MD,a Chul-Min Ahn, MD,a Yong-Joon Lee, MD,a Jung-Sun Kim, MD,a Byeong-Keuk Kim, MD,a Myeong-Ki Hong, MD, a Hyeon Chang Kim, MD, b Cheol Woong Yu, MD,c Jae-Hwan Lee, MD, d Seung-Whan Lee, MD,e Young Jin Youn, MD, f Jong Kwan Park, MD,g Chang-Hwan Yoon, MD, h,i Seung Woon Rha, MD,j Pil-Ki Min, MD, k Seung-Hyuk Choi, MD, l In-Ho Chae, MD, h,i Donghoon Choi, MD, a on behalf of the K-VIS Investigators
doi : 10.1016/j.jcin.2023.05.002
Volume 16, Issue 13, 10 July 2023, Pages 1640-1650
Is Drug-Coated Balloon the Real Winner for Femoropopliteal Artery Intervention?∗
Francesco Liistro, MD
doi : 10.1016/j.jcin.2023.05.048
Volume 16, Issue 13, 10 July 2023, Pages 1651-1653
Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent Implantation: Risk Factors and Clinical Outcomes
Andrew Holden, MBC HB,a Yann Gouëffic, MD, PH D, b William A. Gray, MD,c Elizabeth J. Davis, PH D, d Ido Weinberg, MD,e Michael R. Jaff, DO d
doi : 10.1016/j.jcin.2023.04.037
Volume 16, Issue 13, 10 July 2023, Pages 1654-1664
Hypoechoic peri-stent areas in duplex ultrasonography (DUS) (ie, “halo�) have been noted following femoropopliteal artery stenting.
Hypoechoic Halos After Femoropopliteal Stenting: Looking Beyond the Borders∗
Salvatore Cassese, MD, PHD, Felix Voll, MD
doi : 10.1016/j.jcin.2023.05.039
Volume 16, Issue 13, 10 July 2023, Pages 1665-1667
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
S. Elissa Altin, MD,a,b Helen Parise, SCD, a Connie N. Hess, MD, MHS, c,d Ning A. Rosenthal, MD, MPH, PH D, e Mark A. Creager, MD,f Herbert D. Aronow, MD,g Jeptha P. Curtis, Mda
doi : 10.1016/j.jcin.2023.05.001
Volume 16, Issue 13, 10 July 2023, Pages 1668-1678
In patients with intermittent claudication (IC), short-term amputation rates from clinical trial data following lower extremity femoropopliteal (FP) peripheral vascular intervention (PVI) are <1% with unknown longer-term rates.
Optimal Management of Femoropopliteal Arterial Disease in Patients With Intermittent Claudication∗
Debabrata Mukherjee, MD, MS
doi : 10.1016/j.jcin.2023.05.040
Volume 16, Issue 13, 10 July 2023, Pages 1679-1681
TAVR in Bicuspid Aortic Stenosis: Current Evidence and Proposal for a Randomized Controlled Trial Design
Philippe Nuyens, MD,a Ole De Backer, MD, P HD, a Janarthanan Sathananthan, MBC HB, MPH,b,c Troels H?jsgaard J?rgensen, MD, PHD, a Hendrik Treede, MD, PH D, d Jonathon A. Leipsic, MD, P HD, b Jeroen J. Bax, MD, PH D, e John G. Webb, MD, b,c Roxana Mehran, MD,f Mao Chen, MD, P HD, g Michael Reardon, MD,h Martin B. Leon, MD, i,j Lars S?ndergaard, MD, DMS C a
doi : 10.1016/j.jcin.2023.04.003
Volume 16, Issue 13, 10 July 2023, Pages 1682-1687
A Case of Obstructive Shock in Bioprosthetic Pulmonic Valve Endocarditis
Ahmad A. Al Turk, MD, Jake Martinez, MD, I-Hui Chiang, MD, Philip A. Gideon, MD, Marvin H. Eng, MD
doi : 10.1016/j.jcin.2023.02.013
Volume 16, Issue 13, 10 July 2023, Pages 1688-1689
Double Device Approach for Percutaneous Closure of Postmyocardial Infarction Ventricular Septal Defect
Elena de Oliveira-Ca?edo, MD, a, * Joan F. Andrés-Cordon, MD, a,b, * Gerard Mart?-Aguasca, MD,c Victoria Vilalta, MD, a Eduard Fern?ndez-Nofrer?as, MD
doi : 10.1016/j.jcin.2023.03.026
Volume 16, Issue 13, 10 July 2023, Pages 1690-1691
Phrenic Nerve Injury Following Bicaval Valve Implantation for Treating Severe Tricuspid Regurgitation
Omar Abdul-Jawad Altisent, MD, a Rishi Puri, MBBS, PH D, b Ander Regueiro, MD, P HD, a Laura Sanchis, MD, PH D, a Marta Sitges, MD, PHD, a Salvatore Brugaleta, MD, P HD, a Manel Sabaté, MD, P HD, a Josep Rodés-Cabau, MD, P HD, a,c Xavi Freixa, MD, P HD
doi : 10.1016/j.jcin.2023.03.048
Volume 16, Issue 13, 10 July 2023, Pages 1692-1693
Distinctive Paravalvular Jets of a Novel Self-Expanding Transcatheter Aortic Valve With a Unique Skirt Design
Elena Romero Dorta, MD,a,b Isabel Mattig, MD, a,b,c,d Lorenz K?sters, a,b Simon H. Sündermann, MD,b,c,e Sebastian Spethmann, MD, a,b,c Karl Stangl, MD, a,b,c Henryk Dreger, MD
doi : 10.1016/j.jcin.2023.05.006
Volume 16, Issue 13, 10 July 2023, Pages 1694-1695
Dual Retrograde Tibial Access Thrombectomy for Acute Limb Ischemia
Kei Ichihashi, MD, Kazuhiro Dan, MD, PHD
doi : 10.1016/j.jcin.2023.04.039
Volume 16, Issue 13, 10 July 2023, Pages 1696-1697
Association of TRI-SCORE With Clinical Outcomes After Transcatheter Tricuspid Valve Repair
Johanna Vogelhuber, MDy *Tetsu Tanaka, MDy Atsushi Sugiura, MD, PhD Natalia Galka, MS Hannah Emmi Hupp-Herschel, MS Marc Ulrich Becher, MD Sebastian Zimmer, MD Georg Nickenig, MD Refik Kavsur, MDz Marcel Weber, MD
doi : 10.1016/j.jcin.2023.04.005
Volume 16, Issue 13, 10 July 2023, Pages 1698-1700
Basal Septal Bulge as Risk Factor for New Conduction Disorders After Transcatheter Aortic Valve Replacement
Tanja Kochy Stephanie Brunner, MDy Federico Moccetti, MD Mathias Wolfrum, MD *Stefan Toggweiler, MD
doi : 10.1016/j.jcin.2023.04.041
Volume 16, Issue 13, 10 July 2023, Pages 1701-1702
Low-Cardiac Output Syndrome After Tricuspid Valve Repair: Insights From the TriValve Registry
Karl-Philipp Rommel, MD Maurizio Taramasso, MD Sebastian Ludwig, MD Guillaume Bonnet, MD, PhD Holger Thiele, MD Martin B. Leon, MD Francesco Maisano, MD Daniel Burkhoff, MD Rebecca T. Hahn, MD Philipp Lurz, MD, PhD
doi : 10.1016/j.jcin.2023.05.010
Volume 16, Issue 13, 10 July 2023, Pages 1703-1705
